Trials / Completed
CompletedNCT01135797
Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials
Retrospective Safety Survey In Patients Included In Phase I-II NV1FGF Clinical Trials
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 164 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to collect retrospectively long term safety data in patients who have participated in the previous phase I-II trials conducted with the compound.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-06-03
- Last updated
- 2011-04-28
Locations
7 sites across 7 countries: United States, Belgium, France, Germany, Italy, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01135797. Inclusion in this directory is not an endorsement.